Label-free enrichment of human pluripotent stem cell-derived early retinal progenitor cells for cell-based regenerative therapies

Stem Cell Reports. 2024 Feb 13;19(2):254-269. doi: 10.1016/j.stemcr.2023.12.001. Epub 2024 Jan 4.

Abstract

Pluripotent stem cell-based therapy for retinal degenerative diseases is a promising approach to restoring visual function. A clinical study using retinal organoid (RO) sheets was recently conducted in patients with retinitis pigmentosa. However, the graft preparation currently requires advanced skills to identify and excise suitable segments from the transplantable area of the limited number of suitable ROs. This remains a challenge for consistent clinical implementations. Herein, we enabled the enrichment of wild-type (non-reporter) retinal progenitor cells (RPCs) from dissociated ROs using a label-free ghost cytometry (LF-GC)-based sorting system, where a machine-based classifier was trained in advance with another RPC reporter line. The sorted cells reproducibly formed retinal spheroids large enough for transplantation and developed mature photoreceptors in the retinal degeneration rats. This method of enriching early RPCs with no specific surface antigens and without any reporters or chemical labeling is promising for robust preparation of graft tissues during cell-based therapy.

Keywords: ghost cytometry; label-free cell sorting; regenerative therapy; retinal degeneration; retinal organoid; retinal progenitor cell; transplantation.

MeSH terms

  • Animals
  • Humans
  • Pluripotent Stem Cells* / transplantation
  • Rats
  • Reactive Oxygen Species
  • Retina
  • Retinal Degeneration* / therapy
  • Retinitis Pigmentosa* / therapy
  • Stem Cell Transplantation / methods

Substances

  • Reactive Oxygen Species